Submitted by Anonymous (not verified) on Tue, 10/16/2018 - 21:47

<ul>
<li>Addressing the opioid use disorder (OUD) epidemic in the United States will require diverse approaches over many years. </li>
<li> Greater integration of medication-assisted treatment (MAT) for OUD in primary care settings would expand access to treatment for this condition.</li>
<li> Models for integrating MAT into primary care vary in structure, however.</li>
</ul> <p>This article in&nbsp;Annals of Internal Medicine, written by&nbsp;several researchers affiliated with the NIDA Clinical Trials Network&nbsp;and of potential interest to those following the CTN&rsquo;s research on MAT and integration of primary care and substance use disorder treatment, summarizes findings of a technical report for the Agency for Healthcare Research and Quality describing MAT models of care for OUD.</p>
<p>The report, based on a&nbsp;literature review and interviews with key informants&nbsp;in the field, describes&nbsp;12 representative models&nbsp;of care for integrating MAT into primary care settings that could be considered for adaptation across diverse health care settings.<br>
<br>
Common components&nbsp;among all 12 models include:</p>
<ul>
<li>pharmacotherapy using buprenorphine or naltrexone,</li>
<li> provider and community education,</li>
<li> coordination and integration of OUD treatment with other medical and psychological needs, and</li>
<li> psychosocial services and interventions.</li>
</ul>
<p>Models vary in how each component is implemented.</p>
<p>Conclusions: Existing MAT models of care can inform expanded implementation in primary care settings. &nbsp;Decisions about adopting MAT models of care should be individualized to address the unique milieu of each implementation setting.</p>

Korthuis PT, McCarty D, Weimer M, et al. Primary care-based models for the treatment of opioid use disorder. Annals of Internal Medicine 2016 (in press). doi: 10.7326/M16-2149 Korthuis PT, McCarty, D, Weimer, M, et al. Primary care-based models for the treatment of opioid use disorder. Annals of Internal Medicine 2016 (in press). Inactive